Three new #obesity drugs—high-dose semaglutide, semaglutide plus cagrilintide, and oral orforglipron—may soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how US$ 23.13 Min. order: 1 piece ★★★★★ 4.9 (136 reviews) Sold : Login>>
D I H E X A is having a moment right now… and I get why. When something gets labeled as “brain repair” or “synapse growth,” it spreads FAST especially in communities US$ 28.33 Min. order: 1 piece ★★★★★ 4.3 (194 reviews) Sold : Login>>
𝐃𝐨𝐜, 𝐬𝐢𝐧𝐜𝐞 𝐦𝐲 𝐰𝐞𝐢𝐠𝐡𝐭 𝐢𝐬 𝐚𝐥𝐫𝐞𝐚𝐝𝐲 𝐝𝐨𝐰𝐧, 𝐜𝐚𝐧 𝐈 𝐫𝐞𝐝𝐮𝐜𝐞 𝐭𝐡𝐞 𝐝𝐨𝐬𝐞/𝐬𝐭𝐨𝐩 𝐭𝐡𝐞 𝐦𝐞𝐝 𝐧𝐨𝐰?” 🤔 US$ 29.23 Min. order: 1 piece ★★★★★ 4.6 (47 reviews) Sold : Login>>
Hepatocyte Growth Factor/MET Activator Rescues Working Memory Deficits after Repeated Mild Traumatic Brain Injury US$ 25.31 Min. order: 1 piece ★★★★★ 4.1 (53 reviews) Sold : Login>>
Dihexa in Clinical Trials: What We've Learned So Far US$ 20.25 Min. order: 1 piece ★★★★★ 4.1 (56 reviews) Sold : Login>>
SEASONS GREETINGS: YOUR INTERACTIVE NEWSLETTER 2025 US$ 21.45 Min. order: 1 piece ★★★★★ 4.8 (245 reviews) Sold : Login>>